Company Filing History:
Years Active: 2016-2025
Title: Noriko Kawabata: Innovator in Pharmaceutical Formulations
Introduction
Noriko Kawabata is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of glaucoma and ocular hypertension. With a total of 10 patents to her name, her work has had a substantial impact on medical science.
Latest Patents
Kawabata's latest patents include innovative pharmaceutical formulations that utilize pyridylaminoacetic acid compounds. One notable patent provides a pharmaceutical preparation for the treatment or prevention of glaucoma or ocular hypertension. This preparation comprises 0.0003 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof. Another significant patent focuses on a pharmaceutical preparation that aims to treat or prevent glaucoma or ocular hypertension, particularly for patients who have not responded adequately to existing therapeutic agents. This preparation has been found to be effective in lowering intraocular pressure in such patients.
Career Highlights
Kawabata is currently associated with Santen Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments for eye conditions that affect millions of people worldwide.
Collaborations
Throughout her career, Kawabata has collaborated with notable colleagues, including Naveed Shams and Hisashi Kawata. These partnerships have fostered innovation and have contributed to the success of her research endeavors.
Conclusion
Noriko Kawabata's contributions to pharmaceutical formulations have made her a key figure in the fight against glaucoma and ocular hypertension. Her innovative patents and collaborations highlight her dedication to improving patient outcomes in the field of ophthalmology.